Načítá se...
Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies
Hematologic malignancies provide a suitable testing environment for cell-based immunotherapies, which were pioneered by the development of allogeneic hematopoietic stem cell transplant. All types of cell-based therapies, from donor lymphocyte infusion to dendritic cell vaccines, and adoptive transfe...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4929926/ https://ncbi.nlm.nih.gov/pubmed/27207792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-12-629089 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|